Google Scholar: Profile https://scholar.google.com/citations?user=gEURAxsAAAAJ&hl=en
 

Research Gate Profile: https://www.researchgate.net/profile/Olayinka-Kotila 

ORCID Profile: https://orcid.org/0000-0002-0674-9085

Email: oa.kotila@mail.ui.edu.ng

Email Address 2:

Research (Ten most recent publications): 1.                Babalola C. P., Kotila O., Samuel B. B., Adetunji O., Gbotosho G. O., Moody J. O., Adeyemi A. M., Adegbola O., Akinyele G., Itiola O. A., Fortunak, J (2024). Building capacity for drug development process in Africa ‒ A workable model. Pharmacy Education, 24(1), p. 1–12. https://doi.org/10.46542/pe.2024.241.112

2.                Babalola C.P., Kotila O., Iwuchukwu O.F. The expanding role of gene-based prescribing for phase II drug-metabolizing enzymes (2023). American Journal of Pharmacotherapy and Pharmaceutical Sciences 2023;024. https://doi.org/10.25259/AJPPS_2023_024  

3.                Coker M.O., Kotila O.A., Adigun T.O., Lawal, T.V., Fagbamigbe, A.F., Makolo, A.U., Salawu, M.M., Ajayi, D.T., Oluniyi, P.E., Oguzie, J.U., Happi, A.N., Hoen, A.G., Babalola, C.P., Ajayi, I.O. (2023). Data science training needs in sub-Saharan Africa: Implications for biomedical research and therapeutics capacity [version 1; peer review: 1 approved]. Open Res Africa 2023, 6:21 (https://doi.org/10.12688/openresafrica.14109.1)

4.                Kotila O.A, Ajayi D., Masimerembwa C., Thelingwani R., Odetunde A, Falusi A.G., Babalola C.P. (2023). Non-compartmental and Population Pharmacokinetic Analysis of Dapsone in Healthy Nigerians: A Pilot Study. British Journal of Clinical Pharmacology https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bcp.15862  

5.                Bright B., Sobande Patrick., Alonge Temitope., Babalola C.P., Musa-Olomu A.A., Ali W., Kotila O., Fajimi N., Itodo E.S., Falayi S., Ajayi D., Olatunji A., Adesope T., Ojeblenu F., Ologunagba M., Aduh , Rotinwa R., Odunfa G., Chukwurah A., Adeyemi S. (2022). Telling the COVID-19 Story – An Overview of Our COVID-19 Study Protocols and Research at Livewell Initiative LWI and Global Public Health University GPHU. European Journal of Clinical and Biomedical Sciences, 8(4), 62-70. https://doi.org/10.11648/j.ejcbs.20220804.12

6.                Nwogu, J.N., Ngene, S.O., Babalola, C.P. Olagunju A., Owen A., Khoo, S.H., Kotila O.A., Berzins B., Okochi, H., Tallerico, R., Ghandi, M., Taiwo, B. (2022). Comparison of efavirenz levels in blood and hair with pharmacy refills as measures of adherence and predictors of viral suppression among people living with HIV in Nigeria. AIDS Research and Therapy Vol. 19: 35 https://doi.org/10.1186/s12981-022-00462-3

7.                Adejumo P.O, Oluwasanu M.M, Atara N.,  Awolude O.,  Kotila O.A., Aniagwu T., Brown B.,   Dzekem B.S., Duncan S., Tito-Ilori M., Ajani O., Lee S.M, Babalola C.P, Ojengbede O, Huo D., Hammad N and Olopade O. (2022). Oncology Training Needs Assessment Among Healthcare Professionals In Nigeria. JCO Global Oncology 8 (2022) e2200017 https://doi.org/10.1200/GO.22.00017  

8.                Olateju O.A., Babalola C.P., Olubiyi O.O., Kotila O.A., Kwasi D.A., Oaikhena A.O., Okeke I.N. (2021). Quinoline Antimalarials Increase the Antibacterial Activity of Ampicillin. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2021.556550    

9.                Arinola G.O., Awolude O.A., Ntekim A., Aniagwu T.I.G., Balogun W.O., Kotila O.A., Oluwasaanu M., Adejumo P.O., Babalola C.P., Ifechukwude O.M., Oyedele O.M., Olopade O.I., Olopade C.O., Ojengbede O. (2020) Ethics and Responsible Conduct of Research: Workshop Report. African Journal of Biomedical Research Vol. 23. SE2: 3-5
10.                Atara, N., Ibraheem, A., Sofoluwe, A.A., Adepoju, T., Oluwasanu, M., Aniagwu, T., Awolude, O., Balogun, W., Kotila, O., Adejumo, P., Babalola, C.P., Arinola, G., Ojengbede, O., Olopade, C.O. and Olopade, O.I. (2020). Implementing Oncology Clinical Trials in Nigeria: A Model for Capacity Building. BMC Health Services Research Vol. 20: 713. https://doi.org/10.1186/s12913-020-05561-3.

Grants and Awards:         a)                MacArthur Foundation Multidisciplinary Research Grant (Grant # 11-97968--000-INP) (Co-Investigator)        October 2009

       b)                Global Health Initiative Fellowship Award, University of Chicago, USA        2010 & 2011 
       c)                MEPIN Year 02 Seed Award (Award number R24TW008878 from the Fogarty International Center)        2012

       d)                Wellcome Trust Bursary Award        2012
       e)                Novartis Scholarship Award – Pharmacometrics Course in Tanzania        2013
       f)                NIH D43 Re-entry Grant Award (1D43TW009112-01A1)        2013
       g)                Tertiary Education Trust Fund (TETFund) - Academic Staff Training and Development Fund (AST&D)        2014

       h)                Thomas-Bassir Biomedical Foundation Small Research Grants        2017
       i)                Travel Grant to attend Fogarty International Centre (FIC) Global Network of Grant Holders and their Grantees Focused on Non-communicable Diseases (NCDs)        2018
       j)                TETFUND Research Project Fund on “Pharmaceutical Quality of Selected Anticancer Drugs (Doxorubicin, Epirubicin and Cyclophosphamide) marked in South West Nigeria (Co-Investigator)        2019
       k)                United States Pharmacopeia (USP) Promoting Quality of Medicines Plus (PQM+) Program – a USAID Cooperative Agreement funded project. Centre for Drug Discovery, Development and Production is a CoreFlex partner with USP        2019
       l)                University of Ibadan Research Foundation (Co-Investigator)        2020
       m)                Tertiary Education Trust Fund (TETFund) Special Covid-19 Intervention Grant (TETFund/DR&D/CE/SI/COV-19/UI/Vol.1) (Co-Investigator)        2020